Showing results (581-590 of 1,018) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|December 3, 2025
Roles of restricted mean survival time and restricted mean time lost in evaluating immune checkpoint inhibitor efficacy for extensive-stage small cell lung cancerSeren Durer, Pingfu Fu, Zhengyi Chen, et al.
Cancer Research Communications|December 1, 2025
Real-World Clinical Oncology Outcomes Associated With the Accelerated Approval PathwayTu My To, Stacey Kowal, James D Chambers, et al.
Cancer Research Communications|December 19, 2024
Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White PatientsSaurabh Mandal, Emily A Teslow, Minxuan Huang, et al.
Cancer Research Communications|December 31, 2024
A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection in High-Risk PopulationsShuaipeng Geng, Shiyong Li, Wei Wu, et al.
Cancer Research Communications|December 12, 2024
Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid LeukemiaHimangshu Sonowal, William G Rice, Raphael Bejar, et al.
Cancer Research Communications|February 11, 2025
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical StudyWilliam C Reinhold, Elisabetta Marangoni, Fathi Elloumi, et al.
Cancer Research Communications|February 10, 2025
Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid TumorsBenedito A Carneiro, Robert M Jotte, Nashat Y Gabrail, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
Cancer Research Communications|February 27, 2025
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of RecurrenceChristopher C Jackson, Jia Jenny Liu, Howard Y Liu, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
Pageof 102